Clinical criteria and biochemical markers for the detection of systolic dysfunction

Citation
K. Yamamoto et al., Clinical criteria and biochemical markers for the detection of systolic dysfunction, J CARD FAIL, 6(3), 2000, pp. 194-200
Citations number
29
Categorie Soggetti
Cardiovascular & Respiratory Systems
Journal title
JOURNAL OF CARDIAC FAILURE
ISSN journal
10719164 → ACNP
Volume
6
Issue
3
Year of publication
2000
Pages
194 - 200
Database
ISI
SICI code
1071-9164(200009)6:3<194:CCABMF>2.0.ZU;2-K
Abstract
Background: This study was designed to assess the use of clinical criteria and biochemical testing to detect systolic dysfunction. Our goal is to deve lop strategies that may enhance the detection and treatment of patients wit h early ventricular dysfunction while reducing the use of echocardiogrphy. Methods and Results: We compared the predictive characteristics of the plas ma brain natriuretic peptide (BNP) concentration with that of a 5-point cli nical score derived from elements of the history, electrocardiogram. and ch est radiograph in outpatients (n = 466) referred for echocardiography becau se of symptoms of heart failure or risk factors for systolic dysfunction. S ystolic dysfunction was defined as an ejection fraction (EF) less than 45% and was present in 10.9% of patients. By receiver operating characteristic analysis, BNP was sensitive and specific for the detection of systolic dysf unction, with an area under the receiver operating characteristic curve for the detection of EF less than 45% of 0.79. The BNP assay was abnormal in 4 1% of patients and identified a group with a high prevalence of systolic dy sfunction (21% with an EF less than 45%), whereas a normal BNP value identi fied a group with a low prevalence of systolic dysfunction (24% with an EF less than 45%). The clinical score was positive in 43% of the population an d identified a group with a high prevalence of systolic dysfunction (24% wi th an EF less than 45%). A normal score identified a group with a low preva lence of systolic dysfunction (1% with an EF less than 45%). Conclusion: This study supports previous studies, which showed that BNP ass ay predicts systolic dysfunction with acceptable sensitivity and specificit y, and it underscores the effectiveness of additional readily available cli nical criteria. Both of these strategies should he considered in screening for left ventricular dysfunction in populations at risk while limiting expe nsive cardiac imaging modalities.